These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 33283384)

  • 1. SOLOIST-WHF and updated meta-analysis: sodium-glucose co-transporter 2 inhibitors should be initiated in patients hospitalized with worsening heart failure.
    Docherty KF; McMurray JJV
    Eur J Heart Fail; 2021 Jan; 23(1):27-30. PubMed ID: 33283384
    [No Abstract]   [Full Text] [Related]  

  • 2. Use of sodium glucose co-transporter 2 inhibitors in acute heart failure: a practical guidance.
    Ferreira JP; Pimenta J; Moura B; Aguiar C; Franco F
    ESC Heart Fail; 2022 Dec; 9(6):4344-4347. PubMed ID: 36004699
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comment on Sodium-Glucose Co-Transporter 2 Inhibitors and Heart Failure.
    Cure E; Cumhur Cure M
    Am J Cardiol; 2020 May; 125(10):1602. PubMed ID: 32241553
    [No Abstract]   [Full Text] [Related]  

  • 4. Meta-Analysis Evaluating the Cardiovascular Efficacy of Sodium-Glucose Co-Transporter-2 Inhibitors in Patients With Heart Failure With Reduced Ejection Fraction According to Baseline Anemia.
    Patoulias D; Papadopoulos C; Fragakis N; Karagiannis A; Doumas M
    Am J Cardiol; 2022 Sep; 179():111-114. PubMed ID: 35871863
    [No Abstract]   [Full Text] [Related]  

  • 5. Meta-Analysis Evaluating the Efficacy of Sodium-Glucose Co-Transporter-2 Inhibitors in Patients With Acute or Recently Decompensated Heart Failure.
    Patoulias D; Doumas M; Kassimis G; Fragakis N; Papadopoulos C
    Am J Cardiol; 2022 Jun; 172():171-172. PubMed ID: 35396145
    [No Abstract]   [Full Text] [Related]  

  • 6. Treatment of Hypertension to Prevent and Treat Heart Failure in Diabetic Patients Should Include Sodium Glucose Co-Transporter 2 Inhibitors.
    Carbone S; Dixon DL; Abbate A
    JACC Heart Fail; 2018 Jan; 6(1):85. PubMed ID: 29284585
    [No Abstract]   [Full Text] [Related]  

  • 7. Sodium glucose co-transporter 2 inhibitors in heart failure with preserved ejection fraction: a systematic review and meta-analysis.
    Tsampasian V; Elghazaly H; Chattopadhyay R; Ali O; Corballis N; Chousou PA; Clark A; Garg P; Vassiliou VS
    Eur J Prev Cardiol; 2022 May; 29(6):e227-e229. PubMed ID: 34850881
    [No Abstract]   [Full Text] [Related]  

  • 8. Treatment of heart failure: the dawn of the era of sodium-glucose co-transporter-2 inhibitors.
    Crea F
    Eur Heart J; 2020 Sep; 41(36):3379-3383. PubMed ID: 33216881
    [No Abstract]   [Full Text] [Related]  

  • 9. Emerging Topics in Heart Failure: Sodium-Glucose Co-Transporter 2 Inhibitors (SGLT2i) in HF.
    Bocchi EA; Biolo A; Moura LZ; Figueiredo Neto JA; Montenegro CEL; Albuquerque DC
    Arq Bras Cardiol; 2021 Feb; 116(2):355-358. PubMed ID: 33656089
    [No Abstract]   [Full Text] [Related]  

  • 10. Sodium-glucose co-transporter-2 inhibitors and protection from cardiovascular death: Is it all about heart failure?
    Caruso I; Cignarelli A; Laviola L; Giorgino F
    Diabetes Obes Metab; 2021 Sep; 23(9):2194-2196. PubMed ID: 34033214
    [No Abstract]   [Full Text] [Related]  

  • 11. Beyond the myocardium: Sodium-glucose co-transporter-2 inhibitors in heart failure.
    Chilton RJ
    Diabetes Obes Metab; 2021 May; 23(5):1215-1218. PubMed ID: 33464709
    [No Abstract]   [Full Text] [Related]  

  • 12. Sodium glucose co-transporter inhibitors and heart failure outcomes across different patient populations.
    Butler J; Anker SD; Filippatos G; Usman MS; Ferreira JP; Zannad F; Packer M
    Eur Heart J; 2021 Dec; 42(48):4887-4890. PubMed ID: 34718518
    [No Abstract]   [Full Text] [Related]  

  • 13. Sodium-glucose co-transporter 2 inhibitors in heart failure: beyond glycaemic control. A position paper of the Heart Failure Association of the European Society of Cardiology.
    Seferović PM; Fragasso G; Petrie M; Mullens W; Ferrari R; Thum T; Bauersachs J; Anker SD; Ray R; Çavuşoğlu Y; Polovina M; Metra M; Ambrosio G; Prasad K; Seferović J; Jhund PS; Dattilo G; Čelutkiene J; Piepoli M; Moura B; Chioncel O; Ben Gal T; Heymans S; de Boer RA; Jaarsma T; Hill L; Lopatin Y; Lyon AR; Ponikowski P; Lainščak M; Jankowska E; Mueller C; Cosentino F; Lund L; Filippatos GS; Ruschitzka F; Coats AJS; Rosano GMC
    Eur J Heart Fail; 2020 Sep; 22(9):1495-1503. PubMed ID: 32618086
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sotagliflozin and decompensated heart failure: results of the SOLOIST-WHF trial.
    Shah SR; Ali A; Ikram S
    Expert Rev Clin Pharmacol; 2021 May; 14(5):523-525. PubMed ID: 33764842
    [No Abstract]   [Full Text] [Related]  

  • 15. Treatment of heart failure with sodium glucose co-transporter-2 inhibitors in people with type 2 diabetes mellitus: current evidence and future directions.
    Sharma A; Butler J; Zieroth S; Giannetti N; Verma S
    Diabet Med; 2019 Dec; 36(12):1550-1561. PubMed ID: 31536660
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardio-Protective Effects of Sodium-Glucose Co-Transporter 2 Inhibitors: Focus on Heart Failure.
    Karangelis D; Mazer CD; Stakos D; Tzifa A; Loggos S; Verma S; Mitropoulos F
    Curr Pharm Des; 2021; 27(8):1051-1060. PubMed ID: 33143620
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sodium-Glucose Co-Transporter-2 Inhibitors Decrease the Odds for Atrial Fibrillation in Subjects with Heart Failure.
    Patoulias D; Papadopoulos C; Doumas M
    J Stroke Cerebrovasc Dis; 2022 Mar; 31(3):106257. PubMed ID: 34953683
    [No Abstract]   [Full Text] [Related]  

  • 18. Meta-analysis Evaluating the Effect of Sodium-Glucose Co-Transporter-2 Inhibitors on the Risk for New-Onset Obstructive Sleep Apnea in Patients With Type 2 Diabetes Mellitus Regardless of Cardiovascular Disease at Baseline.
    Patoulias D; Dimosiari A; Michailidis T; Roditis P; Lampropoulos S
    Am J Cardiol; 2022 Sep; 179():116-117. PubMed ID: 35868896
    [No Abstract]   [Full Text] [Related]  

  • 19. Sodium-glucose co-transporter 2 inhibitors and acute heart failure.
    Groenewegen A; Rutten FH
    Eur J Heart Fail; 2020 Apr; 22(4):723-725. PubMed ID: 32072715
    [No Abstract]   [Full Text] [Related]  

  • 20. Sodium-glucose co-transporter-2 inhibitors: know the patient and the drugs.
    Lim LL; Chan JCN
    Hong Kong Med J; 2019 Aug; 25(4):268-270. PubMed ID: 31416989
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.